[1] |
Biessels GJ, Staekenborg S, Brunner E, et al. Risk of dementia in diabetes mellitus: A systematic review[J]. Lancet Neurol, 2006, 5(1):64-74.
|
[2] |
Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications[J]. Lancet. Neurol, 2019, 18(7):684-696.
|
[3] |
Fazekas F, Barkhof F, Wahlund LO, et al. CT and MRI rating of white matter lesions[J]. Cerebrovasc Dis, 2002, 13(Suppl 2):31-36.
|
[4] |
Adami A, Rossato G, Cerini R, et al. Right-to-left shunt does not affect white matter lesion load in migraine patients[J]. Stroke, 2007, 38(2):459-459.
|
[5] |
de Bresser J, Kuijf HJ, Zaanen K, et al. White matter hyperintensity shape and location feature analysis on brain MRI; proof of principle study in patients with diabetes[J]. Sci Rep, 2018, 8(1):1893.
|
[6] |
Werhane ML, Thomas KR, Bangen KJ, et al. Arterial stiffening moderates the relationship between type-2 diabetes mellitus and white matter hyperintensity burden in older adults with mild cognitive impairment[J]. Front Aging Neurosci, 2021, 13: 716638.
|
[7] |
Love S, Miners JS. Small vessel disease, neurovascular regulation and cognitive impairment: post-mortem studies reveal a complex relationship, still poorly understood[J]. Clin Sci (Lond), 2017, 131(14):1579-1589.
|
[8] |
Petersen RC. Mild cognitive impairment clinical trials[J]. Nat Rev Drug Discov, 2003, 2(8):646-653.
|
[9] |
Yang SQ, Xu ZP, Xiong Y, et al. Altered intranetwork and internetwork functional connectivity in type 2 diabetes mellitus with and without cognitive impairment[J]. Sci Rep, 2016, 6:32980.
|
[10] |
Hase Y, Horsburgh K, Ihara M, et al. White matter degeneration in vascular and other ageing-related dementias[J]. J Neurochem, 2018, 144(5):617-633.
|
[11] |
Tamura Y, Araki A. Diabetes mellitus and white matter hyperintensity[J]. Geriatr Gerontol Int, 2015, 15(Suppl 1):34-42.
|
[12] |
Tamura Y, Kimbara Y, Yamaoka T, et al. White matter hyperintensity in elderly patients with diabetes mellitus is associated with cognitive impairment, functional disability, and a high glycoalbumin/glycohemoglobin ratio[J]. Front Aging Neurosci, 2017, 9:220-225.
|
[13] |
Li J, Ogbole G, Aribisala B, et al. Association between white matter hyperintensities and stroke in a west african patient population: evidence from the stroke investigative research and educational network Study[J]. Neuroimage, 2020, 215:116789.
|
[14] |
Tamura Y, Araki A. Diabetes mellitus and white matter hyperintensity[J]. Geriatr Gerontol Int, 2015, 15(Suppl 1):34-42.
|
[15] |
Park K, Yasuda N, Toyonaga S, et al. Significant association between leukoaraiosis and metabolic syndrome in healthy subjects[J]. Neurology, 2007, 69(10):974-978.
|
[16] |
Anan F, Masaki T, Iwao T, et al. The role of microalbuminuria and insulin resistance as significant risk factors for white matter lesions in Japanese type 2 diabetic patients[J]. Curr Med Res Opin, 2008, 24(6):1561-1567.
|
[17] |
Inzitari D, Pracucci G, Poggesi A, et al. Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort[J]. BMJ, 2009, 339:b2477.
|
[18] |
Kim BJ, Lee SH, Kang BS, et al. Diabetes increases large artery diseases, but not small artery diseases in the brain[J]. J Neurol, 2008, 255(8):1176-1181.
|
[19] |
Del Bene A, Ciolli L, Borgheresi L, et al. Is type 2 diabetes related to leukoaraiosis? An updated review[J]. Acta neurologica Scandinavica, 2015, 132(3):147-155.
|
[20] |
Burke SN, Barnes CA. Neural plasticity in the ageing brain[J]. Nat Rev Neurosci, 2006, 7(1):30-40.
|
[21] |
Biesbroek JM, Weaver NA, Biessels GJ. Lesion location and cognitive impact of cerebral small vessel disease[J]. Clin Sci (Lond), 2017, 131(8):715-728.
|
[22] |
Pozorski V, Oh JM, Okonkwo O, et al. Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease[J]. Neuroimage Clin, 2019, 23:101870.
|
[23] |
de Bresser J, Kuijf HJ, Zaanen K, et al. White matter hyperintensity shape and location feature analysis on brain MRI; proof of principle study in patients with diabetes[J]. Sci Rep, 2018, 8(1):1893.
|
[24] |
Gao S, Chen Y, Sang F, et al. White matter microstructural change contributes to worse cognitive function in patients with type 2 diabetes[J]. Diabetes, 2019, 68(11):2085-2094.
|
[25] |
Li C, Zuo Z, Liu D, et al. Type 2 diabetes mellitus may exacerbate gray matter atrophy in patients with early-onset mild cognitive impairment[J]. Front Neurosci, 2020, 14:856.
|
[26] |
Moran C, Beare R, Wang W, et al. Type 2 diabetes mellitus, brain atrophy, and cognitive decline[J]. Neurology, 2019, 92(8):e823-e830.
|
[27] |
Jokinen H, Melkas S, Madureira S, et al. Cognitive reserve moderates long-term cognitive and functional outcome in cerebral small vessel disease[J]. J Neurol Neurosurg Psychiatry, 2016, 87(12):1296-1302.
|
[28] |
Rizzo MR, Barbieri M, Boccardi V, et al. Dipeptidyl peptidase-4 inhibitors have protective effect on cognitive impairment in aged diabetic patients with mild cognitive impairment[J]. J Gerontol A Biol Sci Med Sci, 2014, 69(9):1122-1131.
|
[29] |
de Havenon A, Majersik JJ, Tirschwell DL, et al. Blood pressure, glycemic control, and white matter hyperintensity progression in type 2 diabetics[J]. Neurology, 2019, 92(11):e1168-e1175.
|